The Cure building has attracted 17 companies across healthcare, including medical technologies, healthcare services, therapeutics, healthcare investment, and non-profits. Residents include Advancium Health Network, Apertura, AstaLynx Global, CobiCure, Concerto Care, Cure Innovation Labs, Coridea, Deerfield Management, EntryPoint Capital, Helaina, Humanity Health, Insilico, Kazia Therapeutics Limited, Lexeo Therapeutics, Nyxoah SA, Protara Therapeutics, and Test Now and Go.
L&K Partners was retained in the construction and interior fit-out of the world-class facility, which includes various space types including move-in ready wet and dry labs, prototype studios, workplace zones, conference space, and state-of-the-art amenities. We are pleased to continue to partner with residents in the building for custom lab modifications and tenant improvement projects.
Read more about the Cure campus HERE